Biocon rises 3% on complete response letter for proposed biosimilar pegfilgrastim News News / News 6 years ago 488 Views comments The US Food and Drug Administration has issued a complete response letter (CRL) for Mylan#39;s biologics license application (BLA), a proposed biosimi... Read more
News More than half of India#39;s gas-fired power plants idle: Piyush Goyal News / News - 6 years ago
News Inflation is crashing, but a rate cut by RBI at its August policy meet not a given News / News - 6 years ago
Comments